Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein (Q35159147)

6 August 2017

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein (English)

1 reference

Middle East respiratory syndrome coronavirus

6 August 2017

0 references

1 reference

1 reference

Nianshuang Wang

2

0 references

author name string

Liwei Jiang

1

1 reference

6 August 2017

Teng Zuo

3

1 reference

6 August 2017

Xuanling Shi

4

1 reference

6 August 2017

Kwok-Man Vincent Poon

5

1 reference

6 August 2017

Yongkang Wu

6

1 reference

6 August 2017

Fei Gao

7

1 reference

6 August 2017

Danyang Li

8

1 reference

6 August 2017

Ruoke Wang

9

1 reference

6 August 2017

Jianying Guo

10

1 reference

6 August 2017

Lili Fu

11

1 reference

6 August 2017

Kwok-Yung Yuen

12

1 reference

6 August 2017

Bo-Jian Zheng

13

1 reference

6 August 2017

Xinquan Wang

14

1 reference

6 August 2017

Linqi Zhang

15

1 reference

6 August 2017

language of work or name

English

0 references

publication date

28 April 2014

1 reference

Science Translational Medicine

6 August 2017

1 reference

6 August 2017

6

1 reference

6 August 2017

234ra59

1 reference

6 August 2017

234

1 reference

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

6 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

A decade after SARS: strategies for controlling emerging coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Identification of MERS-CoV in dromedary camels

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Family cluster of Middle East respiratory syndrome coronavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Hospital outbreak of Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

The molecular biology of coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Isolating and engineering human antibodies using yeast surface display

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Tools to therapeutically harness the human antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008140

10.1126/SCITRANSLMED.3008140

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference